Alder Biopharmaceuticals Inc (ALDR) - Financial and Strategic SWOT Analysis Review

January 2020 | 46 pages | ID: A4B80DCCC21EN
GlobalData

Abstracts

Alder Biopharmaceuticals Inc (ALDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Alder Biopharmaceuticals Inc (Alder) is a biopharmaceutical company which develops, produces and commercializes monoclonal antibody therapeutics for the treatment of migraine, and rheumatoid arthritis (RA). It is investigating its pipeline products clazakizumab, a novel monoclonal antibody for the treatment of RA; and ALD1910 and eptinezumab for prevention and treatment of migraine. The company's pipeline is based on its proprietary technologies such as the antibody selection system (ABS) and MabXpress, a novel yeast based antibody production system. Alder is headquartered in Bothell, Washington, the US.

Alder Biopharmaceuticals Inc Key Recent Developments

Sep 17,2019: Lundbeck signs $1.95bn deal to buy Alder BioPharmaceuticals
Sep 16,2019: Alder (ALDR) alert: Johnson Fistel investigates proposed sale of Alder BioPharmaceuticals
Aug 06,2019: Alder BioPharmaceuticals reports second quarter 2019 financial and operating results
May 02,2019: Alder BioPharmaceuticals reports first quarter 2019 financial and operating results
Apr 08,2019: Alder BioPharmaceuticals appoints Nadia Dac as Chief Commercial Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Alder Biopharmaceuticals Inc - Key Facts
Alder Biopharmaceuticals Inc - Key Employees
Alder Biopharmaceuticals Inc - Key Employee Biographies
Alder Biopharmaceuticals Inc - Major Products and Services
Alder Biopharmaceuticals Inc - History
Alder Biopharmaceuticals Inc - Company Statement
Alder Biopharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Alder Biopharmaceuticals Inc - Business Description
R&D Overview
Alder Biopharmaceuticals Inc - Corporate Strategy
Alder Biopharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Alder Biopharmaceuticals Inc - Strengths
Alder Biopharmaceuticals Inc - Weaknesses
Alder Biopharmaceuticals Inc - Opportunities
Alder Biopharmaceuticals Inc - Threats
Alder Biopharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Alder Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Alder Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Alder Biopharmaceuticals Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Sep 17, 2019: Lundbeck signs $1.95bn deal to buy Alder BioPharmaceuticals
Sep 16, 2019: Alder (ALDR) alert: Johnson Fistel investigates proposed sale of Alder BioPharmaceuticals
Aug 06, 2019: Alder BioPharmaceuticals reports second quarter 2019 financial and operating results
May 02, 2019: Alder BioPharmaceuticals reports first quarter 2019 financial and operating results
Apr 08, 2019: Alder BioPharmaceuticals appoints Nadia Dac as Chief Commercial Officer
Feb 25, 2019: Alder BioPharmaceuticals reports fourth quarter and full year 2018 financial and operating results
Jan 22, 2019: Alder BioPharmaceuticals names Paul Streck, M.D. chief medical officer

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Alder Biopharmaceuticals Inc, Key Facts
Alder Biopharmaceuticals Inc, Key Employees
Alder Biopharmaceuticals Inc, Key Employee Biographies
Alder Biopharmaceuticals Inc, Major Products and Services
Alder Biopharmaceuticals Inc, History
Alder Biopharmaceuticals Inc, Subsidiaries
Alder Biopharmaceuticals Inc, Key Competitors
Alder Biopharmaceuticals Inc, Ratios based on current share price
Alder Biopharmaceuticals Inc, Annual Ratios
Alder Biopharmaceuticals Inc, Annual Ratios (Cont...1)
Alder Biopharmaceuticals Inc, Annual Ratios (Cont...2)
Alder Biopharmaceuticals Inc, Interim Ratios
Alder Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Alder Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Alder Biopharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Alder Biopharmaceuticals Inc, Performance Chart (2014 - 2018)
Alder Biopharmaceuticals Inc, Ratio Charts
Alder Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Alder Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

COMPANIES MENTIONED

Concert Pharmaceuticals Inc
Innoviva Inc
Immupharma Plc
Codexis Inc
Benitec Biopharma Ltd
Imugene Ltd
Incyte Corp